ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

BRUIN 313 and 314 Trials Open the Door for Noncovalent Bruton Tyrosine Kinase Inhibition as Initial Therapy for Chronic Lymphocytic Leukemia.

Matthew S DavidsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.